Value Proposition


First-and-Best-in-Class based on Discovery of Novel Mast Cell Biology

Discovery of a novel receptor that controls the entire mast cell activity enables novel small molecules with superior therapeutic efficacy and safety.

Superior Therapeutic Potential and Safety

Multi-symptom and organ treatment, potentially disease-modifying combined with expected excellent safety.

Accelerated Drug Development

Lead program following a unique accelerated drug development to clinics.

High Probability for Clinical Success

Expected high probability for clinical phase success based on in human proof-of-concept evidence.

Significant Market Potential

Multi-product-in-a-pipeline in several disease indications with high unmet need.

Social Impact

Bringing urgently needed therapeutics to wide range of patients.